Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.22 – $2.50
90% from low
Exchange
OTC Link
CS
MARPAI INC A
No one on the platform currently holds MRAI.
No tracked institution reports a position in MRAI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-06-29 | 1-for-4reverse |
No one on the platform has traded MRAI yet.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$MRAI Marpai Reports Second Quarter 2026 Financial Results - Successful turnaround leads to lower operating costs and improved gross margin; debt restructuring and subsequent financing strengthen capital structure https://www.prnewswire.com/news-releases/marpai-reports-second-quarter-2026-financial-results-302851424.html?tc=eml_cleartime
View on StockTwits ↗$MRAI Marpai Announces $12 Million Private Placement led by Mitchell Companies https://www.prnewswire.com/news-releases/marpai-announces-12-million-private-placement-led-by-mitchell-companies-302838261.html?tc=eml_cleartime
View on StockTwits ↗$MRAI $26.4 million debt reduction and incredible new revenue this year
View on StockTwits ↗$MRAI Marpai Inc. Announces Debt Restructuring Agreements with JGB Capital and AXA, Reducing Debt Service by $26.4 Million Through 2027 and Enhances Near term Liquidity https://www.prnewswire.com/news-releases/marpai-inc-announces-debt-restructuring-agreements-with-jgb-capital-and-axa-reducing-debt-service-by-26-4-million-through-2027-and-enhances-near-term-liquidity-302829258.html
View on StockTwits ↗$MRAI Outstanding article that hits the mark on MRAI's current state. So if you want to refresh your MRAI insights or learn about MRAI from scratch, this is a must read. https://everyticker.com/quote/MRAI/analysis/marpai-s-0-31-gamble-can-a-turnaround-pbm-story-survive-its-liquidity-cliff-otcqx-mrai
View on StockTwits ↗$MRAI Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026 https://www.prnewswire.com/news-releases/marpai-inc-announces-unprecedented-growth-with-192-000-new-estimated-member-lives-across-tpa-and-marpairx-pbm-platforms-expects-to-achieve-positive-cash-flow-and-ebitda-beginning-august-2026--302782220.html
View on StockTwits ↗$MRAI Q1 '26 Earnings Results & Recap Marpai Inc. reported revenue of $4.4M for the three months ended March 31, 2026, a decrease of $974K from the prior year. The company's net loss increased to $3.2M, with net cash used in operating activities totaling $477K.
View on StockTwits ↗$MRAI MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 Profitability https://www.prnewswire.com/news-releases/marpai-reports-first-quarter-2026-financial-results-302773847.html
View on StockTwits ↗$MRAI Marpai, Inc. Announces Significant New Business Wins across TPA and MarpaiRx; Solidifies Forecast for Profitability https://www.prnewswire.com/news-releases/marpai-inc-announces-significant-new-business-wins-across-tpa-and-marpairx-solidifies-forecast-for-profitability-302768280.html
View on StockTwits ↗$MRAI Marpai, Inc. Secures Major Strategic Marketing Collaboration to Continue Acceleration of MarpaiRx Growth Nationwide https://www.prnewswire.com/news-releases/marpai-inc-secures-major-strategic-marketing-collaboration-to-continue-acceleration-of-marpairx-growth-nationwide-302731537.html?tc=eml_cleartime
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Beat consensus in 2 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-05-15 | $-0.10 | $-0.13 | -30.0% |
| 2026-03-25 | $-0.10 | $-0.26 | -160.0% |
| 2025-11-12 | $-0.09 | $-0.20 | -122.2% |
| 2025-08-13 | $-0.09 | $-0.28 | -211.1% |
| 2025-05-14 | $-0.09 | $-0.21 | -133.3% |
| 2025-03-26 | $-0.23 | $-0.14 | +39.1% |
| 2024-11-11 | $-0.31 | $-0.30 | +3.2% |
| $39M |
| — |
| CLYYFCelyad Oncology S.A. | $0.28 | +0.00% | $13M | — |
| CNTMFFluent Corp. | $0.02 | -5.33% | $10M | — |
Source: Financial Modeling Prep · peers by sector/industry